FLUID-PHASE IMMUNORADIOMETRIC ASSAY FOR THE DETECTION OF QUALITATIVE ABNORMALITIES OF FACTOR-VII VON WILLEBRAND FACTOR IN VARIANTS OF VON WILLEBRANDS DISEASE

被引：0
|
作者：
GIRMA, JP
ARDAILLOU, N
MEYER, D
LAVERGNE, JM
LARRIEU, MJ
机构：
来源：
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1979年 / 93卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：926 / 939
页数：14
相关论文
共 50 条
  • [31] DDAVP-INDUCED ALTERATIONS IN THE MULTIMERIC COMPOSITION OF FACTOR-VIII-VON-WILLEBRAND FACTOR IN NORMAL AND VON-WILLEBRANDS DISEASE PLASMA
    RUGGERI, ZM
    LOMBARDI, R
    MANNUCCI, PM
    ZIMMERMAN, TS
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 167 - 167
  • [32] AGGLUTINATION OF FORMALIN-FIXED, PLATELET-TYPE VON WILLEBRANDS DISEASE PLATELETS BY HUMAN VON WILLEBRAND FACTOR
    TAKAHASHI, H
    SHIBATA, A
    THROMBOSIS AND HAEMOSTASIS, 1984, 52 (03) : 267 - 270
  • [33] A Comparative Evaluation of an Automated Functional Assay for Von Willebrand Factor Activity in Type 1 Von Willebrand Disease
    Lai, Shiue-Wei
    Chang, Chia-Yau
    Cheng, Shin-Nan
    Hu, Shu-Hsia
    Lai, Chung-Yu
    Chen, Yeu-Chin
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 5167 - 5174
  • [34] Evaluation of a new turbidimetric assay for von Willebrand factor activity useful in the general screening of von Willebrand disease
    Pinol, Montse
    Sales, Miquel
    Costa, Marta
    Tosetto, Alberto
    Canciani, Maria Teresa
    Federici, Augusto B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (05): : 712 - 713
  • [35] Monitoring of von Willebrand factor inhibitors in patients with type 3 von Willebrand disease using a quantitative assay
    Miller, Connie H.
    HAEMOPHILIA, 2021, 27 (05) : 823 - 829
  • [36] The use of recombinant activated factor VII in congenital and acquired von Willebrand disease
    Franchini, Massimo
    Veneri, Dino
    Lippi, Giuseppe
    BLOOD COAGULATION & FIBRINOLYSIS, 2006, 17 (08) : 615 - 619
  • [37] Treatment of acute haemorrhage in a patient with type 3 von Willebrand's disease and alloantibodies against von Willebrand factor with recombinant activated factor VII
    Dietrich A.
    Scholz U.
    Schreiter D.
    European Surgery, 2005, 37 (6) : 336 - 339
  • [38] Phenotype assignment of Type 2 von Willebrand disease (VWD) variants by a single ELISA-based assay of von Willebrand factor (VWF) functions
    Roberts, J. C.
    Morateck, P. A.
    Christopherson, P. A.
    Yan, K.
    Hoffmann, R. G.
    Gill, J. C.
    Montgomery, R. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 90 - 91
  • [39] MOLECULAR VARIATION OF FACTOR-VIII VON-WILLEBRAND FACTOR (F.VIII-VWF) PROTEIN IN VON-WILLEBRANDS DISEASE (VWD)
    GRALNICK, HR
    COLLER, BS
    SULTAN, Y
    CLINICAL RESEARCH, 1975, 23 (03): : A274 - A274
  • [40] Compound heterozygosity for novel von Willebrand factor genetic variants associated with von Willebrand disease in two Chinese patients
    Wang, Yaqin
    Wang, Xiong
    Lu, Yanjun
    Zhang, Ai
    Yu, Wen
    Hu, Qun
    Liu, Aiguo
    Huang, Jin-feng
    BLOOD COAGULATION & FIBRINOLYSIS, 2023, 34 (01) : 33 - 39
12345